COMPARISON OF ISRADIPINE AND ENALAPRIL EFFECTS ON REGIONAL CAROTID CIRCULATION IN PATIENTS WITH HYPERTENSION WITH UNILATERAL INTERNAL CAROTID-ARTERY STENOSIS
Se. Akopov et Na. Simonian, COMPARISON OF ISRADIPINE AND ENALAPRIL EFFECTS ON REGIONAL CAROTID CIRCULATION IN PATIENTS WITH HYPERTENSION WITH UNILATERAL INTERNAL CAROTID-ARTERY STENOSIS, Journal of cardiovascular pharmacology, 30(5), 1997, pp. 562-570
This randomized, double-blind, placebo-controlled study was aimed at d
etecting cerebrovascular effects of isradipine and enalapril in patien
ts with moderate hypertension depending on the presence and grade on u
nilateral stenosis of internal carotid artery (ICA). We evaluated caro
tid vascular resistance by using Doppler analysis and regional cerebra
l blood flow (rCBF) by using Xe-133-clearance technique before and aft
er a single 5-mg oral dose of isradipine, enalapril, or placebo. Their
effects were randomly and consecutively tested in 73 patients with es
sential hypertension subdivided into three groups: without carotid occ
lusive lesions, with moderate (50-75%), and with severe (76-99%) unila
teral asymptomatic ICA stenosis. There were no differences in age, gen
der, and antihypertensive effects of the drugs between these three sub
groups. Three major variants of cerebrovascular drug effects were obse
rved: absence of changes (variant I), decrease in carotid vascular res
istance with increase in rCBF and elimination of side-to-side asymmetr
y (variant II), and increase in carotid vascular resistance with furth
er reduction of rCBF ipsilaterally ICA stenosis, and increased side-to
-side asymmetry (variant III). Frequency of variant III was significan
tly higher in patients with severe ICA stenosis. Enalapril produced va
riant I of cerebrovascular effects in most patients examined; variant
III was observed only in 13% of patients with severe ICA stenosis. Isr
adipine produced variant I of cerebrovascular effects much less freque
ntly than did enalapril. For this drug, variant II was most typical in
patients without ICA stenosis and with moderate ICA stenosis. In 43.5
% of patients with severe ICA stenosis, however, isradipine produced r
eduction of cerebral perfusion. Presumably the presence of ICA stenosi
s, especially >75%, increases the risk of cerebrovascular disorders in
antihypertensive therapy. In patients with severe ICA stenosis, treat
ment with enalapril appears to be safer than that with isradipine.